CORT — Corcept Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapFalling Star

Annual balance sheet for Corcept Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	224	432	368	385	377
Net Total Accounts Receivable
Net Total Receivables	27.6	31.1	41.1	54	59.8
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	266	499	459	472	485
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1.52	1.78	0.315	8.01	6.47
Long Term Investments
Other Long Term Assets
Total Assets	424	583	622	841	837
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	47.5	72.5	105	141	166
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	48	81.6	115	161	189
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	376	502	507	680	648
Total Liabilities & Shareholders' Equity	424	583	622	841	837
Total Common Shares Outstanding